DM
CELG

Deerfield Management’s Celgene Corp CELG Stock Holding History

Deerfield Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,500
Closed -$403K – 150
2015
Q1 		$403K Buy
+3,500
New +$418K 0.01% 120

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deerfield Management's CELG Position: Q2 2015 in Review

Deerfield Management sold out of Celgene Corp (CELG) in Q2 2015, closing a stake of 3,500 shares — an estimated $403K sold.

Deerfield Management first reported a position in CELG in Q1 2015 and held it in 1 quarter. The position peaked at $403K in Q1 2015. 1,201 funds tracked by Wall St. Rank hold CELG as of Q2 2015.

  • Deerfield Management reported no remaining Celgene Corp position as of Q2 2015 after selling out during the quarter.
  • Deerfield Management sold 3,500 Celgene Corp shares in Q2 2015, an estimated $403K.
  • Deerfield Management first reported a position in Celgene Corp in Q1 2015 and held it in 1 quarter.
  • Deerfield Management's Celgene Corp position peaked at $403K in Q1 2015.
  • 1,201 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2015.

Based on Deerfield Management's 13F filing for Q2 2015, filed 14 Aug 2015.